Recent Updates
Recently added Catalysts
BCRX Positive Sentiment Score: 70/100

BioCryst to Present at 42nd Annual J.P. Morgan Healthcare Conference

Wednesday, January 3, 2024 1 min read
Key Takeaway: BioCryst Pharmaceuticals, Inc. has announced its participation in the 42nd Annual J.P. Morgan Healthcare Conference, scheduled for January 9, 2024, at 6:00 p.m. ET in San Francisco. This conference is significant within the healthcare sector, providing a platform for companies to present their strategies and updates. Interested parties can access the live audio webcast and replay through the company's official website.

Market Sentiment Analysis

POSITIVE FACTORS

  • BioCryst is actively participating in a notable healthcare conference.
  • The event presents an opportunity for BioCryst to showcase its advancements.
  • Engagement in prominent conferences can enhance corporate visibility.

Full Press Release Details

RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024, at 6:00 p.m. ET.
Link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.
About BioCryst Pharmaceuticals

Frequently Asked Questions

When will BioCryst present at the J.P. Morgan Conference?

BioCryst will present on January 9, 2024, at 6:00 p.m. ET.

Where can I watch the BioCryst presentation live?

The live audio webcast can be accessed on BioCryst's website.

What is the date of the J.P. Morgan Healthcare Conference?

The conference takes place on January 9, 2024.

What is BioCryst Pharmaceuticals' stock symbol?

The stock symbol for BioCryst Pharmaceuticals is BCRX.

Is there a replay for the BioCryst presentation?

Yes, a replay of the presentation will be available on their website.

Tags: BCRX Viatris Investor Conferences Healthcare BioCryst Healthcare Conference J.P. Morgan biopharmaceuticals
Last updated: Jan 3, 2024